| 摘要 |
PCT No. PCT/FR98/00712 Sec. 371 Date May 25, 1999 Sec. 102(e) Date May 25, 1999 PCT Filed Apr. 8, 1998 PCT Pub. No. WO98/44919 PCT Pub. Date Oct. 15, 1998Use of at least one aminothiol ester derivative for the preparation of a pharmaceutical composition intended to increase the inhibition of a character resistant to the induction of apoptosis of transformed cells, this character being due to the bc12 gene present in these cells. The pharmaceutical composition is more particularly intended to treat pathologies chosen from breast cancers, B cell lymphomas, leukaemias, neuroblastomas, adenocarcinomas of the prostate, prolactinomas and other pituitary adenomas. |
